Further experimental studies, involving both overexpression and knockdown of lncRNA PDIA3P1, revealed that this lncRNA protected cancer cells from undergoing doxorubicin-induced apoptosis, thereby enabling tumor xenografts to grow more rapidly and become more resistant to doxorubicin treatment.112. Here, PDIA3P1 is linked to cancer.